Taking people in Olaszország2. fázis
Fully hybrid 18F-PSMA PET/MRI as one-stop approach for the diagnosis of clinically significant prostate cancer
Key facts
- Where
- Milan, OlaszországSee the site
- Phase
- 2. fázis
Where in Olaszország
- Ospedale San Raffaele S.r.l.Milan, OlaszországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Ospedale San Raffaele S.r.l.
- Trial code
- EU 2024-512859-21-00
- Record updated
- 2026. szeptember 8.
- Original description
To determine the diagnostic accuracy of 18F-PSMA PET/MRI for the diagnosis of clinically relevant prostate cancerRead full original descriptionShow less
To determine the diagnostic accuracy of 18F-PSMA PET/MRI for the diagnosis of clinically relevant prostate cancer
Inclusion: Patients 18 years of age or older, identified as suspects for clinically significant prostate cancer; Ability to undergo all protocol scrutiny; Ability to provide informed consent.
Exclusion: Previous diagnosis of prostate cancer; Contraindications to perform the MRI examination (e.g. claustrophobia, pacemaker, estimated GFR less than or equal to 50mls/min); Contraindications to perform the prostate biopsy.